---
title: Signant Health vs SPRIM PRO
slug_a: signanthealth
slug_b: sprim-pro
site: cro
review_signal_gate: closed
canonical_path: /compare/signanthealth/sprim-pro
---

# Signant Health vs SPRIM PRO

Side-by-side profile data from each company listing on this directory.

## Signant Health

- Profile: [/companies/signanthealth](/companies/signanthealth)

Signant Health — Clinical trial technology and services provider with 30 years of experience supporting thousands of trials and 25% of novel drug approvals (FDA/EMA, 2021–2024). Offers eClinical solutions, protocol guidance from 50+ in-house scientists and clinicians, and global operational scale.

Services: 11. Modalities: 1. Indications: 3. Locations: 8. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Vaccine

### Indications

- Oncology
- Neurology
- Psychiatry

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## SPRIM PRO

- Profile: [/companies/sprim-pro](/companies/sprim-pro)

SPRIM PRO — Clinical trial and strategic consulting CRO offering innovation-enabled trial solutions, digital training, patient engagement programs, and regulatory consulting across multiple therapeutic areas including oncology, CNS, cardiovascular, and rare disease.

Services: 10. Modalities: 0. Indications: 9. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Oncology
- Immunology
- Neurology
- Cardiovascular
- Infectious Disease
- Rare Disease
- Dermatology
- Gastroenterology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)